A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia
収録刊行物
-
- Blood
-
Blood 95 2530-2535, 2000